🦠💊 An international research team has developed a new treatment approach for severe COVID-19, potentially enabling faster recovery and reduced mortality. Results from the Phase II study show that the FasL inhibitor Asunercept allows recovery in an average of 8 days—compared to 13 days in the control group. 📊🔬
Read more ➡️ https://uni.koeln/V3TPT
📰 https://www.sciencedirect.com/science/article/pii/S2589537024004589?via%3Dihub
[#]UniKöln #UniCologne #COVID19 #Research #Health #Medicine #Therapy #ClinicalStudy #Recovery #Immunology
=> More informations about this toot | More toots from UniKoeln@wisskomm.social
text/gemini
This content has been proxied by September (3851b).